A child who has perennial allergic rhinitis has been using an intranasal glucocorticoid. The provider has ordered montelukast [Singulair] to replace the glucocorticoid, because the child has frequent nosebleeds
When teaching this child's parents about montelukast, the nurse will include which statement? a. "Montelukast is also effective for treating infectious rhinitis."
b. "Montelukast may cause behavior changes in your child."
c. "Montelukast will treat both congestion and rhinitis."
d. "Montelukast works best when combined with a topical decongestant."
B
Montelukast can cause rare but serious neuropsychiatric effects in patients, and parents should be warned of this possibility. It is not useful for treating infectious rhinitis. It does not affect con-gestion. It is not necessary to add a topical decongestant when using this drug for allergic rhini-tis.
You might also like to view...
The nurse is preparing to admit patients who have been the victim of a blast injury. The nurse should expect to treat a large number of patients who have experienced what type of injury?
A) Chemical burns B) Spinal cord injury C) Meningeal tears D) Tympanic membrane rupture
At the conclusion of a health history the nurse determines that a patient is at risk for kidney cancer. What did the nurse assess to make this clinical decision?
Select all that apply. 1. obesity 2. over 55 years of age 3. genetic predisposition 4. female 5. bladder calculi
The nurse is admitting a client with an exacerbation of asthma. The medication list includes albuterol, salmeterol, budesonide, cromolyn, and zafirlukast
The client takes these medicines every day, except for the albuterol. When planning the client's care, the nurse recognizes that: 1. The client is taking too many medications, and several should be discontinued. 2. The therapy is adequate, except that the client should be using the albuterol daily. 3. The client needs several additional preparations if the asthma control standards of the Agency for Healthcare Research and Quality are to be met. 4. The client's combination of medications is appropriate according to current practice guidelines.
A patient who had a Mantoux test for tuberculosis two days ago has a 2 mm area of erythema at the site of the test. How should this finding be identified?
A. Follow up with a tine test B. Positive for tuberculosis C. Negative D. Unable to be determined